Structural basis of antagonizing the vitamin K catalytic cycle for anticoagulation

Citations Over TimeTop 10% of 2020 papers

Abstract

Vitamin K antagonists are widely used anticoagulants that target vitamin K epoxide reductases (VKOR), a family of integral membrane enzymes. To elucidate their catalytic cycle and inhibitory mechanism, we report 11 x-ray crystal structures of human VKOR and pufferfish VKOR-like, with substrates and antagonists in different redox states. Substrates entering the active site in a partially oxidized state form cysteine adducts that induce an open-to-closed conformational change, triggering reduction. Binding and catalysis are facilitated by hydrogen-bonding interactions in a hydrophobic pocket. The antagonists bind specifically to the same hydrogen-bonding residues and induce a similar closed conformation. Thus, vitamin K antagonists act through mimicking the key interactions and conformational changes required for the VKOR catalytic cycle.

Related Papers

• → R- and S-Warfarin inhibition of vitamin K and vitamin K 2,3-epoxide reductase activities in the rat.(1982)140 cited
• → Vitamin K1, vitamin K1 epoxide and warfarin interrelationships in the dog(1981)9 cited
• → Characterization and purification of the vitamin K1 2,3 epoxide reductase system from rat liver(2001)24 cited
• → Coumarins and the vitamin K-K epoxide cycle. Lack of resistance to coumatetralyl in warfarin-resistant rats(1976)23 cited
• → Inhibition by warfarin of liver microsomal vitamin K-reductase in warfarin-resistant and susceptible rats(1984)12 cited